ARTICLE | Company News
ARRY, ICOS in target deal
August 14, 2001 7:00 AM UTC
Array and Icos agreed to research and develop I-domain allosteric site (IDAS) targeted small molecule compounds for two specific disease targets. ICOS will fund joint research activities of lead gener...